MedGenesis Therapeutix Inc. MedGenesis Therapeutix Inc.
 

Company

News ] Our People ] [ Our Partners ]

Key Collaborations

MedGenesis has a number of key collaborations in place that provide significant competitive advantages and create additional barriers to competitive entry.


Biovail
Biovail Corporation is Canada's largest publicly traded pharmaceutical company.
 

Biovail Laboratories International SRL
MedGenesis and Biovail have entered into an agreement to collaborate on the development of GDNF in Parkinson's disease and potentially other CNS indications. Biovail develops and commercializes medicines that provide meaningful benefits to people living with unmet medical needs with a focus on disorders of the central nervous system.


BrainLAB AG
With over 950 people in 16 offices around the world, BrainLAB develops, manufactures, and markets software-driven medical equipment.
 

BrainLAB AG
MedGenesis recognizes that real-time image guidance is critical to effective CED drug delivery and has entered into a strategic supply agreement with BrainLAB, the leading provider of image guidance solutions for neurosurgery and the maker of iPlan® Flow software.


Northern Lipids Inc.
Northern Lipids Inc (NLI) is a Contract Research Organization (CRO) that specializes in developing lipid-based (liposome, emulsion, micelle) drug delivery systems.
 

Northern Lipids Inc.
MedGenesis has a collaborative relationship with Northern Lipids Inc. (NLI), a contract firm specializing in the development of lipid-based formulations. MedGenesis works with NLI for the production of GMP-standard liposomes for use in CED clinical trials.


Renishaw plc
Renishaw is a world leader in metrology and spectroscopy, with research, development, manufacturing, sales and service operations in more than 30 countries.
 

Renishaw plc
MedGenesis has entered into a strategic supply agreement with Renishaw, a renowned engineering firm that, among others areas, is engaged in cutting edge work on next generation therapeutic delivery systems for the CNS.


Page last updated: 29 June 2010

 

 

© MedGenesis Therapeutix Inc.